Treatment of cognitive impairment in Alzheimer's disease

In Alzheimer's disease, cognition now responds to several drugs. Anticholinesterases target the acetylcholine deficit. In mild-to-moderate Alzheimer's disease, they all provide significant benefit versus placebo on the Alzheimer's Disease Assessment ScheduleCognitive Section (ADAS-Cog...

Descripción completa

Detalles Bibliográficos
Autor principal: Burns, Alistair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2003
Materias:
Pharmacological Aspects
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181714/
https://www.ncbi.nlm.nih.gov/pubmed/22034058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181714/
https://www.ncbi.nlm.nih.gov/pubmed/22034058

Ejemplares similares